Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

216.93 -0.53 (-0.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,081,161
Open 215.96
Bid (Size) 217.00 (2)
Ask (Size) 217.20 (10)
Prev. Close 217.46
Today's Range 214.48 - 218.48
52wk Range 214.48 - 296.67
Shares Outstanding N/A
Dividend Yield 3.25%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top-Ranked Dividend Stocks: A Smarter Way To Boost Your Retirement Income
Here are three dividend-paying stocks retirees should consider for their nest egg portfolio. 
Via Talk Markets
A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know.
Biotech-giant Amgen aims to launch a rival. 
Via The Motley Fool

Performance

YTD
-17.09%
-17.09%
1 Month
-9.20%
-9.20%
3 Month
-7.47%
-7.47%
6 Month
-23.24%
-23.24%
1 Year
-15.51%
-15.51%

More News

Read More
3 Dogs of the Dow for High-Yield Investors
Via InvestorPlace
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Via The Motley Fool
Check Out What Whales Are Doing With AMGN
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Amgen's Debt Overview
Via Benzinga
Here's How Much You Would Have Made Owning Amgen Stock In The Last 15 Years
Via Benzinga
3 Safe Dividend Stocks to Beat Inflation
Via The Motley Fool
The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Via Investor's Business Daily
Stock Market Rally Hits 2023 Highs As Big Techs Lead; Tesla, Walmart, On Holding In Focus: Weekly Review
Via Investor's Business Daily
Why Horizon Therapeutics Stock Is Crashing Today
Via The Motley Fool
Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?
Via MarketBeat
Topics Bonds
Exposures Debt Markets
The FTC, Amgen, And Horizon: A New Hurdle For Biotech Deal Making Or Regulatory Overreach?
Via Talk Markets
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings
Via MarketBeat
Exposures Product Safety
TScan Therapeutics Shares Fall After Preliminary Data Highlight In Leukemia Patients
Via Benzinga
FDA Signals Support For Pfizer's Maternal RSV Shot Ahead Of Adcomm, Pfizer Raises $31B In Debt To Fund Seagen Deal
Via Benzinga
FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?
Via The Motley Fool
Is This Dow Jones Stock a Buy for Income Investors?
Via The Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
Via The Motley Fool
FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A
Via Benzinga
Why These 2 Large-Cap Stocks Dropped 10%-Plus on Tuesday
Via The Motley Fool
Former SVB CEO Blames Fed & Media Hype For Collapse, FTC Plans Lawsuit to Block Horizon Therapeutics $28B Takeover, Home Depot Lowers Annual Outlook: Today's Top Stories
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.